TY  - RPRT
TI  - Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models
AU  - High, P. C.
AU  - Liang, Z.
AU  - Guernsey-Biddle, C.
AU  - Subramanian, S.
AU  - Shyu, Y.-M.
AU  - Aldana, A. M.
AU  - Toh, Y.
AU  - Carmon, K. S.
PY  - 2025
DO  - 10.1101/2025.06.18.660406
UR  - https://www.biorxiv.org/content/10.1101/2025.06.18.660406v1
ID  - 10.1101/2025.06.18.660406
ER  -